[go: up one dir, main page]

MA24585A1 - Formes posologiques de sertraline a liberation retardee - Google Patents

Formes posologiques de sertraline a liberation retardee

Info

Publication number
MA24585A1
MA24585A1 MA25144A MA25144A MA24585A1 MA 24585 A1 MA24585 A1 MA 24585A1 MA 25144 A MA25144 A MA 25144A MA 25144 A MA25144 A MA 25144A MA 24585 A1 MA24585 A1 MA 24585A1
Authority
MA
Morocco
Prior art keywords
dosage forms
delayed release
release sertraline
sertraline dosage
delayed
Prior art date
Application number
MA25144A
Other languages
English (en)
Inventor
J Curatolo William
L Friedman Hylar
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA24585(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA24585A1 publication Critical patent/MA24585A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA25144A 1997-07-01 1998-06-30 Formes posologiques de sertraline a liberation retardee MA24585A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
MA24585A1 true MA24585A1 (fr) 1998-12-31

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25144A MA24585A1 (fr) 1997-07-01 1998-06-30 Formes posologiques de sertraline a liberation retardee

Country Status (40)

Country Link
EP (1) EP1007024B1 (fr)
JP (1) JP3786715B2 (fr)
KR (1) KR100369698B1 (fr)
CN (4) CN1475209A (fr)
AP (1) AP1199A (fr)
AR (1) AR038394A2 (fr)
AT (1) ATE245415T1 (fr)
AU (1) AU727152B2 (fr)
BG (1) BG64742B1 (fr)
BR (1) BR9809895A (fr)
CA (1) CA2290969C (fr)
DE (1) DE69816624T2 (fr)
DK (1) DK1007024T3 (fr)
DZ (1) DZ2547A1 (fr)
EA (1) EA001906B1 (fr)
ES (1) ES2202858T3 (fr)
GT (1) GT199800091A (fr)
HN (1) HN1998000099A (fr)
HR (1) HRP980376B1 (fr)
HU (1) HUP0301787A3 (fr)
ID (1) ID23187A (fr)
IL (2) IL152304A0 (fr)
IS (1) IS5267A (fr)
MA (1) MA24585A1 (fr)
NO (1) NO996519L (fr)
NZ (1) NZ501249A (fr)
OA (1) OA11247A (fr)
PA (1) PA8454201A1 (fr)
PE (1) PE84399A1 (fr)
PL (1) PL337799A1 (fr)
PT (1) PT1007024E (fr)
SI (1) SI1007024T1 (fr)
SK (1) SK173299A3 (fr)
TN (1) TNSN98122A1 (fr)
TR (1) TR199903295T2 (fr)
TW (1) TW575437B (fr)
UA (1) UA63953C2 (fr)
UY (1) UY25068A1 (fr)
WO (1) WO1999001122A1 (fr)
ZA (1) ZA985710B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000025752A1 (fr) 1998-11-02 2000-05-11 Church, Marla, J. Composition a liberation modifiee multiparticulaire
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
CA2374039C (fr) * 1999-05-20 2011-01-11 Elan Corporation Plc Preparations d'inhibiteurs specifiques du recaptage de la serotonine a liberation multiparticulaire regulee
DK1225881T3 (da) 1999-09-03 2006-06-12 Apbi Holdings Llc Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
IL150850A0 (en) * 2000-02-10 2003-02-12 Bpsi Holdings Inc Enteric coating compositions containing acrylic resin
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
PT1377276E (pt) * 2001-04-10 2011-12-30 Sun Pharma Advanced Res Co Ltd Composição de libertação temporizada por pulso
CA2457385A1 (fr) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Preparation enterique de fluoxetine
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (fr) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Dispositif d'administration de médicaments à plusieurs unités pour libération pulsatile ou prolongée
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (fr) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company Procédé pour le filage-éclair de torons de polymères secs à partir de film-fibrilles plexifilamentaires
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
ES2202858T3 (es) 2004-04-01
JP2000513751A (ja) 2000-10-17
CN1475209A (zh) 2004-02-18
AP9801278A0 (en) 1998-06-30
CN1494899A (zh) 2004-05-12
EP1007024B1 (fr) 2003-07-23
PA8454201A1 (es) 2000-09-29
EA001906B1 (ru) 2001-10-22
ATE245415T1 (de) 2003-08-15
DK1007024T3 (da) 2003-11-17
IL133081A0 (en) 2001-03-19
BG64742B1 (bg) 2006-02-28
NO996519D0 (no) 1999-12-28
BG103916A (en) 2000-07-31
HUP0301787A3 (en) 2005-04-28
SI1007024T1 (en) 2003-12-31
UY25068A1 (es) 2000-12-29
BR9809895A (pt) 2000-08-01
AP1199A (en) 2003-08-28
NO996519L (no) 2000-02-29
PL337799A1 (en) 2000-09-11
AU7545198A (en) 1999-01-25
DE69816624D1 (de) 2003-08-28
HUP0301787A2 (hu) 2003-11-28
PT1007024E (pt) 2003-11-28
JP3786715B2 (ja) 2006-06-14
ID23187A (id) 2000-03-23
CA2290969C (fr) 2004-02-17
TW575437B (en) 2004-02-11
NZ501249A (en) 2001-06-29
EP1007024A1 (fr) 2000-06-14
HK1027982A1 (en) 2001-02-02
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
SK173299A3 (en) 2000-11-07
AR038394A2 (es) 2005-01-12
ZA985710B (en) 2000-01-10
CN1151783C (zh) 2004-06-02
CA2290969A1 (fr) 1999-01-14
OA11247A (en) 2002-11-19
CN1475208A (zh) 2004-02-18
KR100369698B1 (ko) 2003-01-30
HRP980376A2 (en) 1999-04-30
HN1998000099A (es) 1998-10-22
WO1999001122A1 (fr) 1999-01-14
CN1261273A (zh) 2000-07-26
DZ2547A1 (fr) 2003-02-08
KR20010013522A (ko) 2001-02-26
IL133081A (en) 2005-09-25
IS5267A (is) 1999-11-23
TNSN98122A1 (fr) 2005-03-15
UA63953C2 (uk) 2004-02-16
EA199900965A1 (ru) 2000-08-28
DE69816624T2 (de) 2004-02-19
AU727152B2 (en) 2000-12-07
HRP980376B1 (en) 2002-12-31
TR199903295T2 (xx) 2000-08-21
PE84399A1 (es) 1999-09-11

Similar Documents

Publication Publication Date Title
EP1126826A4 (fr) Composition a liberation modifiee multiparticulaire
EP0807433A4 (fr) Preparation a liberation prolongee
EP1125586A4 (fr) Particules a liberation prolongee
ATE321119T1 (de) Riechstofffreisetzungssystem
DK1600154T3 (da) Osmotisk doseringsform med forlænget frigivelse
NO20010919D0 (no) Forlenget frigjøring bukkal bioadhesiv tablett
EE200100134A (et) Kiiresti vabastav tablett
MA24585A1 (fr) Formes posologiques de sertraline a liberation retardee
DE69816760D1 (de) Trennfolie
DE69728337D1 (de) Fahrradfelgenbremse
ID22369A (id) Gandaran untuk suatu lampu pelepasan
NO993944L (no) Utlösermekanisme
DE59804724D1 (de) Fadenbremse
NO996520L (no) Oppløste sertralinblandinger
DE69812401D1 (de) Schnellkupplung
DE69814051D1 (de) Trennmittel
DE69822254D1 (de) Trommelbremsvorrichtung
DE69811783D1 (de) Trommelbremse
DE69837458D1 (de) Fahrradbremsanlage
DE59809342D1 (de) Bremsvorrichtung
FI981576L (fi) Irrokepaperi
DE69934545D1 (de) Fahrradfelgenbremse
DE59807945D1 (de) Fadenbremse
DE69819494D1 (de) Flachdruck
DE69810616D1 (de) Flachdruck